A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC
Atevirdine mesylate, Zidovudine, Zalcitabine - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | | 2021-11-04 |
A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
Zidovudine, Zalcitabine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 180 | | 2021-11-04 |
A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
Saquinavir, Zidovudine, Zalcitabine - HIV Infections | Phase 3 | Completed | Hoffmann-La Roche | 3000 | | 2005-06-24 |
A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients
Zidovudine, Zalcitabine, Didanosine - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1200 | | 2021-11-04 |
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
Bleomycin sulfate, Vincristine sulfate, Doxorubicin hydrochloride - Sarcoma, Kaposi, HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 72 | | 2021-10-29 |
The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
Ritonavir, Nelfinavir mesylate, Efavirenz - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 300 | | 2021-11-01 |
A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past
Zidovudine, Zalcitabine, Didanosine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 654 | | 2021-11-04 |
Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia
Indinavir sulfate, Lamivudine, Stavudine - HIV Infections, Hemophilia A | Phase 4 | Completed | Merck Sharp & Dohme LLC | 55 | | 2005-06-24 |
A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs
Saquinavir, Lamivudine, Stavudine - HIV Infections | Phase 2 | Completed | Hoffmann-La Roche | 140 | | 2005-06-24 |
A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine
Saquinavir, Zalcitabine - HIV Infections | Phase 2 | Completed | Hoffmann-La Roche | 900 | | 2005-06-24 |
The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
Saquinavir, Nevirapine, Zidovudine - HIV Infections | Phase 2 | Completed | Parexel | 225 | | 2005-06-24 |
Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients
Filgrastim, Cytarabine, Zidovudine - HIV Infections, Leukoencephalopathy, Progressive Multifocal | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 90 | | 2021-11-01 |
Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.
Zalcitabine - HIV Infections | Not applicable | Completed | Hoffmann-La Roche | | | 2005-06-24 |
A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002
Zidovudine, Zalcitabine - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 120 | | 2021-11-03 |
A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection
Zidovudine, Zalcitabine - HIV Infections | Phase 3 | Completed | Hoffmann-La Roche | 528 | | 2005-06-24 |
The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease
Zidovudine, Zalcitabine, Didanosine - HIV Infections | Not applicable | Completed | Glaxo Wellcome | | | 2005-06-24 |
A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment
Ritonavir, Nelfinavir mesylate, Nevirapine - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 217 | | 2021-10-29 |
The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT
Lamivudine, Zidovudine, Zalcitabine - HIV Infections | Phase 3 | Completed | Glaxo Wellcome | 325 | | 2005-06-24 |
A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
Zidovudine, Zalcitabine - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 750 | | 2021-11-02 |
A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT
Zalcitabine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 140 | | 2021-10-27 |